Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Nurturing Hacks: Shrewdness from Experienced Mothers and Fathers- How we came to be: Scientists get first look at the evolution of early complex animals
- People are getting their news from AI – and it’s altering their views
- Red Sea arena: Yemen’s Houthis open fourth front in Iran war, with global implications
- Figure out How to Forestall Tooth Staining
- Renewables cover over 50% of German electricity consumption in Q1
- Collins Foods to offload 20 Taco Bell outlets in Australia
- 13 must-see moon events in 2026: Eclipses, supermoons, conjunctions and more
- Islamic State group militants claim capture and execution of a Nigerian brigadier general
